Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunocellular Therapeutics, Ltd. (IMUC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immunocellular Therapeutics, Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 822411.
Total stock buying since 2014: $76,149.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $6,750.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2015 | 98,000 | $57,149 | 0 | $0 | 25,000 | $6,750 |
2014 | 21,000 | $19,000 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2015-11 | 10,000 | $4,350 | 0 | $0 | 0 | $0 |
2015-09 | 0 | $0 | 0 | $0 | 25,000 | $6,750 |
2015-02 | 88,000 | $52,799 | 0 | $0 | 0 | $0 |
2014-08 | 21,000 | $19,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-11-30 | Gengos Andrew (President and CEO) | Buy | 10,000 | .43 | 4,350 |
2015-09-28 | Yu John S (Director) | Option Ex | 25,000 | .27 | 6,750 |
2015-02-18 | Gringeri Anthony (Senior VP Strategic Resources) | Buy | 30,000 | .60 | 18,000 |
2015-02-18 | Gengos Andrew (President and CEO) | Buy | 41,333 | .60 | 24,799 |
2015-02-18 | Fractor David (VP of Finance) | Buy | 16,667 | .60 | 10,000 |
2014-08-21 | Gringeri Anthony (Senior VP Strategic Resources) | Buy | 11,000 | .91 | 10,010 |
2014-08-14 | Gengos Andrew (President and CEO) | Buy | 10,000 | .90 | 8,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMUC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immunocellular Therapeutics, Ltd. (symbol IMUC, CIK number 822411) see the Securities and Exchange Commission (SEC) website.